Search Results - "Butt, Roeum"

271: A study to explore the variation of treatment verification matching of MRI-derived CTV using CBCT by Butt, Roeum, Krishnan, Aisling, Megias, Daniel

Get full text

276: Two-year GI and GU toxicity results from prostate SABR treatment by Butt, Roeum, Williams, Angela, Nariyangadu, Prasana, Kroiss, Mariana, Megias, Daniel

Get full text

2970: Ongoing protocol compliance of radiotherapy planning within the ATNEC trial (NCT04109079) by nabi, Zohal, Diez, Patricia, Butt, Roeum, Jackson, Gareth, Wheatley, Duncan, Anandadas, Carmel, Marshall, Andrea, Nicholls, Sophie, Hammonds, Natalie, Goyal, Amit

Get full text

The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planning by Chiu, Kevin, Hoskin, Peter, Gupta, Amit, Butt, Roeum, Terparia, Samsara, Codd, Louise, Tsang, Yatman, Bhudia, Jyotsna, Killen, Helen, Kane, Clare, Ghoshray, Subhadip, Lemon, Catherine, Megias, Daniel

“…Radiologist input in peer review of head and neck radiotherapy has been introduced as a routine departmental approach. The aim was to evaluate this practice…”
Get full text

Practice patterns in ongoing neoadjuvant ATNEC trial for patients with cT1-3N1M0 breast cancer: node marking, response to neoadjuvant chemotherapy(NACT) and breast conservation rates by Goyal, Amit, Marshall, Andrea, Nicholls, Sophie, Hammonds, Natalie, Elsberger, Beatrix, Wheatley, Duncan, Shaaban, Abeer, Puri, Shama, Rose, Janice, Edwards, Helen-Teresa, Butt, Roeum, Ahmed, Samreen, Higgins, Helen, Dunn, Janet

Get full text

ATNEC: A multicenter, randomized trial investigating whether axillary treatment can be avoided in patients with T1-3N1M0 breast cancer with no residual cancer in the lymph glands after neoadjuvant chemotherapy by Goyal, Amit, Cramp, Sophie, Marshall, Andrea, Hammonds, Natalie, Wheatley, Duncan, Elsberger, Beatrix, Puri, Shama, Homer, Tara, Vale, Luke, Butt, Roeum, Nabi, Zohal, Rose, Janice, Edwards, Helen Teresa, Ahmed, Samreen, Shaaban, Abeer, Bruce, Julie, Gasson, Sophie, Higgins, Helen, Dunn, Janet

“…TPS615 Background: Neoadjuvant chemotherapy (NACT) results in eradication of cancer in the axillary nodes in 40-70% of patients. This raises questions about…”
Get full text

Abstract OT1-04-01: ATNEC: A multi-centre, randomised trial investigating whether axillary treatment can be avoided in T1-3N1M0 breast cancer patients with no residual cancer in the lymph glands after neoadjuvant chemotherapy (clinicaltrials.gov: nct04109079) by Goyal, Amit, Cramp, Sophie, Marshall, Andrea, Wheatley, Duncan, Hammonds, Natalie, Puri, Shama, Homer, Tara, Vale, Luke, Butt, Roeum, Mir, Romaana, Rose, Janice, Edwards, Helen Teresa, Ahmed, Samreen, Shaaban, Abeer, Elsberger, Beatrix, Bruce, Julie, Gasson, Sophie, Speirs, Valerie, Shaw, Jacqui, Higgins, Helen, Dunn, Janet

“…Abstract Background: For patients who are node positive to start at presentation and are found to have a complete nodal tumour response (ypN0) post neoadjuvant…”
Get full text

POSNOC—POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes by Goyal, Amit, Mann, G Bruce, Fallowfield, Lesley, Duley, Lelia, Reed, Malcolm, Dodwell, David, Coleman, Robert E, Fakis, Apostolos, Newcombe, Robert, Jenkins, Valerie, Whitham, Diane, Childs, Margaret, Whynes, David, Keeley, Vaughan, Ellis, Ian, Fairbrother, Patricia, Sadiq, Shabina, Monson, Kathryn, Montgomery, Alan, Tan, Wei, Vale, Luke, Homer, Tara, Badger, Heath, Haines, Rachel Helen, Lewis, Mickey, Megias, Daniel, Nabi, Zohal, Singh, Preetinder, Caraman, Andrei, Miles, Elizabeth, Mir, Romaana, Davis, Daniel, Grieve, Teresa, Mitchell, Eleanor, Haydock, Rebecca, Brittain, Clare, Upton, Clare, Craig, Sarah, Shafayat, Aisha, Gidman, Charlotte, Ozolins, Mara, Ternent, Laura, Francis, Nicole, Probert, Flonda, Paksec, Lisa, Lucas, Rose, Dempsey, Annette, Thornton, Rochelle, Butt, Roeum, Price, Hannah, Thompson, Alastair, Ring, Alistair, Sharma, Nisha, Lee, Peter Barrett, Wolfarth, Julie, White, Ian, Cutress, Ramsey, Bliss, Judith, Rea, Daniel, Dubsky, Peter

“…IntroductionACOSOG-Z0011(Z11) trial showed that axillary node clearance (ANC) may be omitted in women with ≤2 positive nodes undergoing breast conserving…”
Get full text

Abstract PO2-23-05: Practice patterns and outcomes in the ongoing neoadjuvant ATNEC trial: node marking, response to NACT and breast conservation rates by Goyal, Amit, Marshall, Andrea, Nicholls, Sophie, Hammonds, Natalie, Elsberger, Beatrix, Wheatley, Duncan, Rose, Janice, Edwards, Helen-Teresa, Shaaban, Abeer, Butt, Roeum, Jackson, Gareth, Homer, Tara, Vale, Luke, Ahmed, Samreen, Puri, Shama, Gasson, Sophie, Bruce, Julie, Higgins, Helen, Dunn, Janet

“…Abstract Background In ATNEC trial, cT1-3N1M0 patients receive NACT followed by SNB/TAD. If the sentinel nodes(SNs) have converted to benign(ypN0), patients…”
Get full text

Abstract OT1-09-02: ATNEC: A multicentre, randomized trial investigating whether axillary treatment can be avoided in T1-3N1M0 breast cancer patients with no residual cancer in the axillary lymph nodes after neoadjuvant chemotherapy by Goyal, Amit, Nicholls, Sophie, Marshall, Andrea, Hammonds, Natalie, Wheatley, Duncan, Elsberger, Beatrix, Rose, Janice, Edwards, Helen-Teresa, Butt, Roeum, Shaaban, Abeer, Puri, Shama, Ahmed, Samreen, Homer, Tara, Vale, Luke, Bruce, Julie, Gasson, Sophie J., Higgins, Helen, Dunn, Janet A.

“…Abstract Background: For patients who are node positive at presentation and are found to have a complete nodal tumour response (ypN0) post-neoadjuvant…”
Get full text

Abstract P5-01-07: Recruitment, clinical equipoise, patient acceptance and compliance in the UK-ANZ POSNOC trial by Goyal, Amit, Bruce, Cydney, Sadiq, Shabina, Lewis, Mickey, Montgomery, Alan, Mann, G Bruce, Badger, Heath, Monson, Kathryn, Jenkins, Valerie, Fallowfield, Lesley, Reed, Malcolm, Dodwell, David, Fairbrother, Patricia, Homer, Tara, Vale, Luke, Butt, Roeum, Miles, Elizabeth, Dowey, Shelley, Matthews, Lucy, Jarrett, Hugh, Jackson, Juliet, Ali, Arfan

“…Abstract Background: POSNOC is a UK-ANZ multicentre, non-inferiority, randomised trial comparing systemic therapy alone with systemic therapy plus Axillary…”
Get full text